Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer35

Select a period of time:

Views

Views
November 20240
December 20240
January 20250
February 20252
March 202517
April 20252
May 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United States3
Brazil1
Spain1
 

Top cities views

Views
Bebedouro1
Council Bluffs1